Form 8-K - Current report:
SEC Accession No. 0001640334-19-000543
Filing Date
2019-04-04
Accepted
2019-04-04 06:16:13
Documents
3
Period of Report
2019-04-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inmb_8k.htm 8-K 13293
2 EXHIBIT 99.1 inmb_99.htm EX-99.1 7456
3 inmb_99img1.jpg GRAPHIC 24509
  Complete submission text file 0001640334-19-000543.txt   55759
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 19731162
SIC: 2836 Biological Products, (No Diagnostic Substances)